Compare Intuitive Surgical, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 13.26%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 18.22%
4
With a growth in Operating Profit of 22.08%, the company declared Very Positive results in Dec 25
5
With ROE of 14.91%, it has a expensive valuation with a 9.21 Price to Book Value
6
High Institutional Holdings at 87.17%
7
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
USD 179,003 Million (Large Cap)
62.00
NA
0.00%
-0.33
16.17%
10.04
Revenue and Profits:
Net Sales:
2,866 Million
(Quarterly Results - Dec 2025)
Net Profit:
800 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.57%
0%
-11.57%
6 Months
5.57%
0%
5.57%
1 Year
-4.77%
0%
-4.77%
2 Years
25.96%
0%
25.96%
3 Years
115.93%
0%
115.93%
4 Years
77.02%
0%
77.02%
5 Years
110.68%
0%
110.68%
Intuitive Surgical, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.22%
EBIT Growth (5y)
22.92%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.53
Tax Ratio
11.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
87.17%
ROCE (avg)
21.41%
ROE (avg)
13.26%
Valuation key factors
Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
9.21
EV to EBIT
60.38
EV to EBITDA
50.15
EV to Capital Employed
12.70
EV to Sales
17.39
PEG Ratio
2.54
Dividend Yield
NA
ROCE (Latest)
21.04%
ROE (Latest)
14.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 220 Schemes (33.14%)
Foreign Institutions
Held by 638 Foreign Institutions (22.67%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
2,866.20
2,413.50
18.76%
Operating Profit (PBDIT) excl Other Income
1,036.00
859.60
20.52%
Interest
0.00
0.00
Exceptional Items
21.30
28.50
-25.26%
Consolidate Net Profit
799.50
688.00
16.21%
Operating Profit Margin (Excl OI)
301.50%
304.50%
-0.30%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 18.76% vs 25.16% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 16.21% vs 12.66% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
10,064.70
8,352.10
20.51%
Operating Profit (PBDIT) excl Other Income
3,570.60
2,804.60
27.31%
Interest
0.00
0.00
Exceptional Items
-7.50
33.90
-122.12%
Consolidate Net Profit
2,876.60
2,337.50
23.06%
Operating Profit Margin (Excl OI)
292.70%
281.20%
1.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 20.51% vs 17.24% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 23.06% vs 28.62% in Dec 2024
About Intuitive Surgical, Inc. 
Intuitive Surgical, Inc.
Pharmaceuticals & Biotechnology
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
Company Coordinates 
Company Details
1020 Kifer Rd , SUNNYVALE CA : 94086-5301
Registrar Details






